Full-Scale Operation of New Jersey Facility
Two-Year Inventory Secured for Tariff Response

With U.S. President Donald Trump announcing plans to impose high tariffs on Korean pharmaceuticals, Celltrion has stated its intention to fundamentally eliminate risks by securing a local production base and inventory in the United States.


Hanmi-Korea Customs Negotiation Follow-up Public-Private Joint Meeting, Chairman Seo Jungjin of Celltrion Speaking. Photo by Yonhap News Agency

Hanmi-Korea Customs Negotiation Follow-up Public-Private Joint Meeting, Chairman Seo Jungjin of Celltrion Speaking. Photo by Yonhap News Agency

View original image

On January 27, Celltrion announced in a “Letter to Shareholders” posted on its website, “We have already structurally eliminated fundamental risks related to tariffs by securing a production facility in Branchburg, New Jersey.”


Previously, on January 26 (local time), President Trump declared that since the Korean National Assembly had not implemented the bilateral trade agreement, tariffs on Korean automobiles, timber, and pharmaceuticals would be immediately raised from 15% to 25%.


Celltrion stated, “The Branchburg production facility in the U.S. began full-scale operations earlier this month,” adding, “We plan to use this facility as a key production hub for our U.S. operations and will swiftly begin production to ensure smooth local product supply through direct sales.”


The company further explained, “Celltrion has developed tailored response strategies for each stage to address uncertainties regarding U.S. tariffs,” and added, “During the period required to produce locally sold products at the U.S. facility, we will utilize two years’ worth of supply already stocked in the U.S. to ensure product sales are unaffected by tariffs.”



Celltrion added, “By preparing mid- to long-term strategies to respond to local U.S. circumstances, we will ensure that any tariff policy has no impact on Celltrion,” and emphasized, “We will continue to closely monitor local market conditions and operate our business without disruption.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing